Algo version: 0.98b
HUTCHMED (China) Limited is listed at the HKSE Exchange
HUTCHMED (China) Limited [0013.HK]
HKSE Sector: Healthcare Industry:Drug Manufacturers—Specialty & Generic

Is HUTCHMED (China) Limited stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

We cannot find any recorded dividends paid in our systems.

Sorry, we do not have any analyst data for this ticker

We cannot find data for HUTCHMED (China) Limited 10 years ago, but if you had invested on Wednesday 30th of June 2021 when the price was HKD60.30, you would have made a loss of HKD-32.40 per share or -53.73%

Yes, the average daily trading liquidity for HUTCHMED (China) Limited is HKD3.26 million. You should therefore be able to get in and out of your positions relatively fast.

HUTCHMED (China) Limited has little of the business financed by loans. This puts the company at lower risk in periods of high inflation where borrowing costs usually go up. With a high cash flow to debt ratio of 2.55, the company's ability to pay off the debt is good. HUTCHMED (China) Limited has a good net profit margin of 12.03% and should have high tolerances against inflation.

We have calculated the inflation risk for HUTCHMED (China) Limited to be low [0.1 of 1]

US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.